采用 3-in-1 策略的治疗性 T 细胞用于胆道癌治疗
Therapeutic T cells with 3-in-1 strategy for the treatment of biliary tract cancer.
临床上,10例晚期胆道癌(BTC)患者接受ScTILs治疗;
71.5分
★★★★☆
DISEASE HUB
FOR TREATMENT
按「中国试验优先 → 正在招募 → 更新更近」排序。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Therapeutic T cells with 3-in-1 strategy for the treatment of biliary tract cancer.
临床上,10例晚期胆道癌(BTC)患者接受ScTILs治疗;
MEMBER ACCOUNT
登录成功会直接打开下一页。